A detailed history of Tredje Ap Fonden transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Tredje Ap Fonden holds 121,589 shares of TMO stock, worth $64.3 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
121,589
Previous 112,549 8.03%
Holding current value
$64.3 Million
Previous $62.2 Million 20.83%
% of portfolio
0.7%
Previous 0.61%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$531.86 - $624.21 $4.81 Million - $5.64 Million
9,040 Added 8.03%
121,589 $75.2 Million
Q2 2024

Aug 12, 2024

SELL
$541.52 - $599.02 $1.83 Million - $2.02 Million
-3,380 Reduced 2.92%
112,549 $62.2 Million
Q1 2024

May 13, 2024

BUY
$528.82 - $599.43 $5.71 Million - $6.47 Million
10,800 Added 10.27%
115,929 $67.4 Million
Q4 2023

Feb 12, 2024

BUY
$431.41 - $532.94 $4.57 Million - $5.64 Million
10,590 Added 11.2%
105,129 $55.8 Million
Q3 2023

Nov 09, 2023

SELL
$498.29 - $574.41 $393,150 - $453,209
-789 Reduced 0.83%
94,539 $47.9 Million
Q2 2023

Aug 11, 2023

BUY
$508.46 - $591.13 $1.26 Million - $1.46 Million
2,478 Added 2.67%
95,328 $49.7 Million
Q1 2023

May 10, 2023

BUY
$535.0 - $604.82 $4.85 Million - $5.49 Million
9,074 Added 10.83%
92,850 $53.5 Million
Q4 2022

Feb 10, 2023

BUY
$484.71 - $571.37 $992,201 - $1.17 Million
2,047 Added 2.5%
83,776 $46.1 Million
Q3 2022

Nov 10, 2022

BUY
$507.19 - $604.49 $10.7 Million - $12.7 Million
20,999 Added 34.58%
81,729 $41.5 Million
Q1 2022

May 09, 2022

SELL
$524.0 - $644.92 $262,000 - $322,460
-500 Reduced 0.82%
60,730 $35.9 Million
Q4 2021

Feb 10, 2022

BUY
$569.0 - $667.24 $532,015 - $623,869
935 Added 1.55%
61,230 $40.9 Million
Q3 2021

Nov 10, 2021

BUY
$509.53 - $609.78 $6.11 Million - $7.32 Million
12,000 Added 24.85%
60,295 $34.4 Million
Q1 2021

May 10, 2021

SELL
$439.85 - $518.83 $747,745 - $882,011
-1,700 Reduced 3.4%
48,295 $22 Million
Q4 2020

Feb 12, 2021

BUY
$435.06 - $527.66 $6.96 Million - $8.44 Million
16,000 Added 47.07%
49,995 $23.3 Million
Q1 2020

May 11, 2020

BUY
$255.3 - $340.05 $524,386 - $698,462
2,054 Added 6.43%
33,995 $9.32 Million
Q4 2019

Feb 10, 2020

SELL
$271.93 - $328.04 $1.25 Million - $1.51 Million
-4,589 Reduced 12.56%
31,941 $10.4 Million
Q3 2019

Nov 12, 2019

BUY
$268.46 - $305.43 $154,901 - $176,233
577 Added 1.6%
36,530 $10.6 Million
Q2 2019

Aug 09, 2019

SELL
$257.51 - $295.55 $1.01 Million - $1.16 Million
-3,941 Reduced 9.88%
35,953 $10.6 Million
Q1 2019

May 10, 2019

BUY
$212.17 - $273.72 $268,819 - $346,803
1,267 Added 3.28%
39,894 $10.9 Million
Q4 2018

Feb 11, 2019

BUY
$208.47 - $251.98 $1.78 Million - $2.15 Million
8,523 Added 28.31%
38,627 $8.65 Million
Q3 2018

Nov 13, 2018

SELL
$205.57 - $244.32 $5.34 Million - $6.34 Million
-25,958 Reduced 46.3%
30,104 $7.35 Million
Q2 2018

Aug 09, 2018

BUY
$203.14 - $219.53 $2.44 Million - $2.64 Million
12,023 Added 27.3%
56,062 $11.6 Million
Q1 2018

May 09, 2018

BUY
$192.98 - $224.11 $1.25 Million - $1.45 Million
6,470 Added 17.22%
44,039 $9.1 Million
Q4 2017

Feb 12, 2018

BUY
$182.03 - $200.37 $842,980 - $927,913
4,631 Added 14.06%
37,569 $7.14 Million
Q3 2017

Nov 13, 2017

BUY
$171.74 - $194.04 $5.66 Million - $6.39 Million
32,938
32,938 $6.24 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $207B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Tredje Ap Fonden Portfolio

Follow Tredje Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tredje Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Tredje Ap Fonden with notifications on news.